Tinlarebant 5 mg´s matching Placebo, LBS-008 clinical trials

Phase 3, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects

This study is looking into a new medication called Tinlarebant for young people with Stargardt disease. It aims to see if the medication is safe and can slow down the development of the condition over about two years, compared to a dummy treatment.